<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05038553</url>
  </required_header>
  <id_info>
    <org_study_id>STU00211593</org_study_id>
    <secondary_id>R01AR064850</secondary_id>
    <nct_id>NCT05038553</nct_id>
  </id_info>
  <brief_title>Chronic Pain in Rheumatoid Arthritis</brief_title>
  <acronym>CPIRA-2</acronym>
  <official_title>CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain Transition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to identify modifiable clinical factors and neurobiological pathways that&#xD;
      lead to the development of chronic pain in patients with early rheumatoid arthritis.&#xD;
      Participants will undergo quantitative sensory testing, a type of testing that involves&#xD;
      assessing response to well-defined, quantifiable painful stimuli, at 0, 3, and 12 months. A&#xD;
      subset of participants will also undergo magnetic resonance imaging at 0 and 12 months to&#xD;
      assess neuroimaging markers that have previously been shown to be involved in chronic pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 10, 2021</start_date>
  <completion_date type="Anticipated">March 9, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 9, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fibromyalgia Survey Criteria</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Arthritis, Rheumatoid</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Patients with early rheumatoid arthritis</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Patients with early rheumatoid arthritis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with early RA recruited from academic medical centers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria for QST:&#xD;
&#xD;
          1. Age ≥18 years&#xD;
&#xD;
          2. Meet either the 1987 or 2010 American College of Rheumatology (ACR)/European League&#xD;
             Against Rheumatism (EULAR) criteria for RA&#xD;
&#xD;
          3. Persistent joint symptoms ≤ 1 year&#xD;
&#xD;
          4. Active inflammatory disease&#xD;
&#xD;
          5. If taking opioids on an as needed (prn) basis, must be able to hold opioid for 48&#xD;
             hours before study procedures&#xD;
&#xD;
          6. If taking NSAIDs, must be able to hold NSAIDS for 24 hours before study procedures&#xD;
&#xD;
          7. If taking a central-acting pain medication, must be on a stable dose and able to stay&#xD;
             on a stable dose throughout study&#xD;
&#xD;
        Exclusion Criteria for QST:&#xD;
&#xD;
          1. Routine, scheduled opioid use&#xD;
&#xD;
          2. Routine, scheduled prednisone dose &gt;10 mg or its equivalent&#xD;
&#xD;
          3. Peripheral neuropathy&#xD;
&#xD;
          4. Peripheral vascular disease&#xD;
&#xD;
          5. Raynaud's phenomenon requiring treatment, manifested by claudication or ischemic rest&#xD;
             pain&#xD;
&#xD;
          6. Uncontrolled blood pressure&#xD;
&#xD;
        Additional Inclusion Criteria for neuroimaging:&#xD;
&#xD;
          1. Age &lt;75 years old&#xD;
&#xD;
          2. Right-handed&#xD;
&#xD;
          3. Ability to lie on their back for the duration of the MRI scans&#xD;
&#xD;
        Additional Exclusion Criteria for neuroimaging:&#xD;
&#xD;
          1. Severe claustrophobia precluding MRI&#xD;
&#xD;
          2. Body mass index &gt;40 kg/m2&#xD;
&#xD;
          3. Pregnant&#xD;
&#xD;
          4. Contraindications to MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yvonne C Lee, MD, MMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kathleen Aren, MPH</last_name>
    <phone>312-503-1824</phone>
    <email>kathleen.aren@northwestern.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary Carns, MS</last_name>
    <phone>312-503-1137</phone>
    <email>m-carns@northwestern.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie Feser</last_name>
      <phone>303-724-7510</phone>
      <email>marie.feser@cuanschutz.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Aren, MPH</last_name>
      <phone>312-503-1824</phone>
      <email>kathleen.aren@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marilyn Towns</last_name>
      <phone>410-550-0579</phone>
      <email>mctowns@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Cole</last_name>
      <phone>734-998-7021</phone>
      <email>colecou@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline E Reidy, MPH</last_name>
      <phone>646-714-6307</phone>
      <email>reidyc@hss.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>September 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 9, 2021</study_first_posted>
  <last_update_submitted>September 4, 2021</last_update_submitted>
  <last_update_submitted_qc>September 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Yvonne Lee</investigator_full_name>
    <investigator_title>Associate Professor of Medicine and Preventive Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

